ArticleThe protein journal2026
Biochemical Characterization of the Staphylococcal Endolysin MV-L with Enhanced Activity Under Optimized Conditions and Effective Removal of MRSA from Surfaces and Biofilms.
Article in The protein journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) remains a major cause of difficult-to-treat infections, largely due to its multidrug resistance and capacity to form persistent biofilms on medical and industrial surfaces. Bacteriophage-derived endolysins have emerged as promising antibacterial agents, but many still require detailed biochemical characterization to support their potential applications. The present study describes the staphylococcal endolysin MV-L expression, purification, and functional analyses, evaluating its ability to control MRSA on surfaces and in biofilms. MV-L was recombinantly produced in Escherichia coli, purified by nickel affinity chromatography; its lytic activity against exponentially growing MRSA was assessed under different physicochemical conditions. Enzyme exhibited optimal activity in slightly alkaline conditions and moderate temperatures; its performance was strongly influenced by ionic strength and divalent cations. Under optimized conditions, MV-L showed markedly increased lytic efficiency and retained activity at low protein concentrations. Beyond planktonic cells, MV-L significantly reduced MRSA loads on glass and stainless steel and disrupted pre-formed biofilms on polystyrene. These findings highlight how buffer composition and ion availability critically modulate MV-L activity and support the concept that tailored endolysins can be integrated as complementary strategies for MRSA control, particularly in scenarios where conventional disinfectants and antibiotics are limited by resistance or poor efficacy against biofilms.
Indexed as
Identifiers
41793616What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.